Process Design
Route discipline for chiral intermediates
How impurity risk is reduced before scale-up reaches multi-kilogram batches.
Read article
Essential chemistry for regulated markets
Specification chemistry, made accountable for generations.
Iff aligns fine chemical synthesis, documentation, and supply continuity for pharmaceutical teams that cannot afford ambiguous quality.
Learn about the program
ELEMENTS BY IFF
Discoveries from our labs
Our technical center documents process learning in a form that sourcing, quality, and application teams can use during supplier qualification.
Process Design
Quality Systems
Batch records that survive audit pressure
Documentation packs are built around analytical traceability, not afterthought paperwork.
Read article
Scale-Up
Transferring morphology from lab to plant
Crystallization, filtration, and drying windows are monitored as linked variables.
Read article
Sustainability
Solvent choices with measurable tradeoffs
We quantify yield, recovery, safety, and carbon signals before recommending change.
Read article
Portfolio Navigation
Discover by material or by industry
ESG Discipline
Our sustainability approach
People
Training, process safety reviews, and exposure controls are built into every scale-up gate.
We prioritize documented handling methods that make buyer audits faster and safer.
- Safety training
- 100% critical roles
Planet
Solvent recovery, energy intensity, and waste streams are measured before production campaigns are released.
Programs focus on practical chemistry decisions that reduce avoidable rework.
- Solvent recovery
- Up to 82%
Chemistry
Each specification is reviewed for assay, residual solvent, moisture, and impurity controls.
Our team connects sustainability targets with validated analytical outcomes.
- Batch review
- Every release
Newsroom
Press Releases
Iff reports stable demand for regulated fine chemical services
Read moreBoard confirms investment in analytical documentation systems
Read moreNew solvent recovery dashboard added to annual disclosures
Read more
Investor Relations
2025 Integrated Report
14% R&D intensity
38 audited supply lanes
97% release conformance
The report summarizes operational reliability, quality system investment, and measurable progress in responsible fine chemical production.
It is written for customers and partners who need a transparent view of risk management before long-term molecule programs begin.
Read the report (PDF) Read Online ReportProduct Finder
Locate pharma intermediates, fine chemicals, and technical packs by chemistry family, quality system, and application stage.
Search portfolioContact Sales
Share your target specification, annual demand, documentation needs, and preferred jurisdiction for a practical sourcing review.